Cellular and humoral immune responses against the Plasmodium vivax MSP-119 malaria vaccine candidate in individuals living in an endemic area in north-eastern Amazon region of Brazil

Malaria Journal

Volumn 12, Issue 1, 2013, Pages

  Riccio, Evelyn Kp ^a,b   Totino, Paulo Rr ^a,b   Pratt Riccio, Lilian R ^a,b   Ennes Vidal, Vitor ^a   Soares, Irene S ^c   Rodrigues, Maurício Martins ^d   De Souza, José Maria ^e   Daniel Ribeiro, Cláudio Tadeu ^a,b   Ferreira Da Cruz, Maria De Fátima ^a,b  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b MINISTÉRIO DA SAÚDE   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^e INSTITUTO EVANDRO CHAGAS   (Brazil)

Author keywords

Antibodies; Cellular response; Malaria; MSP 119; Plasmodium vivax

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G2 ANTIBODY; IMMUNOGLOBULIN G3 ANTIBODY; IMMUNOGLOBULIN G4 ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; INTERLEUKIN 10; MALARIA VACCINE; MEROZOITE SURFACE PROTEIN 1; PLASMODIUM VIVAX MEROZOITE SURFACE PROTEIN 1 19; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; BRAZIL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CELL ISOLATION; CELL PROLIFERATION; CELLULAR IMMUNITY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RESPONSE; ENDEMIC DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; EX VIVO STUDY; FEMALE; HUMAN; HUMORAL IMMUNITY; MALE; PARASITE PREVALENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PLASMODIUM VIVAX MALARIA; PROTEIN BLOOD LEVEL; SCHOOL CHILD;

ADOLESCENT; ADULT; AGED; ANTIBODIES, PROTOZOAN; BRAZIL; CELL PROLIFERATION; CHILD; ENDEMIC DISEASES; FEMALE; HUMANS; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERFERON-GAMMA; INTERLEUKIN-10; LEUKOCYTES, MONONUCLEAR; MALARIA, VIVAX; MALE; MEROZOITE SURFACE PROTEIN 1; MIDDLE AGED; PLASMODIUM VIVAX; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84883854248     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-12-326     Document Type: Article

References (61)

1. WHO, World Malaria Report 2012 Geneva: World Health Organization 2012 http://www.who.int/malaria/publications/world-malaria-report-2012/en/
2. Demographic risk factors for severe and fatal vivax and falciparum malaria among hospital admissions in northeastern Indonesian Papua. Barcus MJ, Basri H, Picarima H, Manyakori C, Sekartuti, Elyazar I, Bangs MJ, Maguire JD, Baird JK, Am J Trop Med Hyg 2007 77 984 991 17984364 (Pubitemid 351837852)
3. Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: a prospective study in Papua, Indonesia. Tjitra E, Anstey NM, Sugiarto P, Warikar N, Kenangalem E, Karyana M, Lampah DA, Price RN, PLoS Med 2008 5 128 10.1371/journal.pmed.0050128 18563962 (Pubitemid 351919110)
4. Plasmodium vivax and mixed infections are associated with severe malaria in children: a prospective cohort study from Papua New Guinea. Genton B, D'Acremont V, Rare L, Baea K, Reeder JC, Alpers MP, Muller I, PLoS Med 2008 5 127 10.1371/journal.pmed.0050127 18563961 (Pubitemid 351919109)
5. Severe Plasmodium vivax malaria: a report on serial cases from Bikaner in northwestern India. Kochar DK, Das A, Kochar SK, Saxena V, Sirohi P, Garg S, Kochar A, Khatri MP, Gupta V, Am J Trop Med Hyg 2009 80 194 198 19190212
6. The pathophysiology of vivax malaria. Anstey NM, Russell B, Yeo TW, Price RN, Trends Parasitol 2009 25 220 227 10.1016/j.pt.2009.02.003 19349210
7. Severe Plasmodium vivax malaria, Brazilian Amazon. Alexandre MA, Ferreira CO, Siqueira AM, Magalhães BL, Mourão MP, Lacerda MV, Alecrim MG, Emerg Infect Dis 2010 16 1611 1614 10.3201/eid1610.100685 20875292
8. Features and prognosis of severe malaria caused by Plasmodium falciparum Plasmodium vivax and mixed Plasmodium species in Papua New Guinean children. Manning L, Laman M, Law I, Bona C, Aipit S, Teine D, Warrell J, Rosanas-Urgell A, Lin E, Kiniboro B, Vince J, Hwaiwhanje I, Karunajeewa H, Michon P, Siba P, Mueller I, Davis TM, PLoS One 2011 6 29203 10.1371/journal.pone.0029203 22216212
9. Changing profile of severe malaria in north Indian children. Yadav D, Chandra J, Aneja S, Kumar V, Kumar P, Dutta AK, Indian J Pediatr 2012 79 483 487 10.1007/s12098-011-0603-x 22090254
10. Understanding the clinical spectrum of complicated Plasmodium vivax malaria: a systematic review on the contributions of the Brazilian literature. Lacerda MV, Mourão MP, Alexandre MA, Siqueira AM, Magalhães BM, Martinez-Espinosa FE, Filho FS, Brasil P, Ventura AM, Tada MS, Couto VS, Silva AR, Silva RS, Alecrim MG, Malar J 2012 11 12 10.1186/1475-2875-11-12 22230294
11. SVS, Boletim Epidemiológico da Malária 2012 http://portal.saude.gov.br/portal/arquivos/pdf/boletim-malaria-2010-2011.pdf
12. 19) and Rusticyanin. Cruz-Gallardo I, Diaz-Moreno I, Diaz-Quintana A, Donaire A, Velazquez-Campoy A, Curd RD, Rangachari K, Birdsall B, Ramos A, Holder AA, De la Rosa MA, J Biol Chem 2013 288 20896 20907 10.1074/jbc.M113.460162 23749994
13. A single fragment of a malaria merozoite surface protein remains on the parasite during red cell invasion and is the target of invasion-inhibiting antibodies. Blackman MJ, Heidrich HG, Donachie S, McBride JS, Holder AA, J Exp Med 1990 172 379 382 10.1084/jem.172.1.379 1694225 (Pubitemid 20217284)
14. A malaria merozoite surface protein (MSP1)-structure, processing and function. Holder AA, Blackman MJ, Burghaus PA, Chappel JA, Ling IT, McCallum-Deighton N, Shai S, Mem Inst Oswaldo Cruz 1992 87 37 42 1343798
15. Structural analysis of the glycosyl-phosphatidylinositol membrane anchor of the merozoite surface proteins-1 and -2 of Plasmodium falciparum. Gerold P, Schofield L, Blackman MJ, Holder AA, Schwarz RT, Mol Biochem Parasitol 1996 75 131 143 10.1016/0166-6851(95)02518-9 8992312 (Pubitemid 26107821)
16. Acquired immune responses to the N- and C-terminal regions of Plasmodium vivax merozoite surface protein 1 in individuals exposed to malaria. Soares IS, Levitus G, Souza JM, Del Portillo HA, Rodrigues MM, Infect Immun 1997 65 1606 1614 9125537 (Pubitemid 27193576)
17. Antibody response to the N and C-terminal regions of the Plasmodium vivax merozoite surface protein 1 in individuals living in an area of exclusive transmission of P. vivax malaria in the north of Brazil. Soares IS, Oliveira SG, Souza JM, Rodrigues MM, Acta Trop 1999 72 13 24 10.1016/S0001-706X(98)00078-3 9924957 (Pubitemid 29062919)
18. Naturally acquired antibody responses to the C-terminal region of merozoite surface protein 1 of Plasmodium vivax in Korea. Park JW, Moon SH, Yeom JS, Lim KJ, Sohn MJ, Jung WC, Cho YJ, Jeon KW, Ju W, Ki CS, Oh MD, Choe K, Clin Diagn Lab Immunol 2001 8 14 20 11139190 (Pubitemid 32061679)
19. Serological detection of Plasmodium vivax malaria using recombinant proteins corresponding to the 19-kDa C-terminal region of the merozoite surface protein-1. Rodrigues MH, Cunha MG, Machado RL, Ferreira OC Jr, Rodrigues MM, Soares IS, Malar J 2003 2 39 10.1186/1475-2875-2-39 14617378
20. IgG isotype to C-terminal 19 kDa of Plasmodium vivax merozoite surface protein 1 among subjects with different levels of exposure to malaria in Brazil. Morais CG, Soares IS, Carvalho LH, Fontes CJ, Krettli AU, Braga EM, Parasitol Res 2005 95 420 426 10.1007/s00436-005-1314-x 15759156 (Pubitemid 40568992)
21. Comparison of naturally acquired antibody responses against the C-terminal processing products of Plasmodium vivax merozoite surface protein-1 under low transmission and unstable malaria conditions in Sri Lanka. Wickramarachchi T, Illeperuma RJ, Perera L, Bandara S, Holm I, Longacre S, Handunnetti SM, Udagama-Randeniya PV, Int J Parasitol 2007 37 199 208 10.1016/j.ijpara.2006.09.002 17055511 (Pubitemid 46074017)
22. Comparative recognition by human IgG antibodies of recombinant proteins representing three asexual erythrocytic stage vaccine candidates of Plasmodium vivax. Barbedo MB, Ricci R, Jimenez MC, Cunha MG, Yazdani SS, Chitnis CE, Rodrigues MM, Soares IS, Mem Inst Oswaldo Cruz 2007 102 335 339 10.1590/S0074-02762007005000040 17568939 (Pubitemid 46869331)
23. 359-798 and their relationship with hematological features in malaria patients from the Brazilian Amazon. Mourão LC, Morais CG, Bueno LL, Jimenez MC, Soares IS, Fontes CJ, Guimarães Lacerda MV, Xavier MS, Barnwell JW, Galinski MR, Braga EM, Microbes Infect 2012 14 730 739 10.1016/j.micinf.2012.02.011 22445906
24. Influence of HLA-DRB1 and HLA-DQB1 alleles on IgG antibody response to the P. vivax MSP-1, MSP-3α and MSP-9 in individuals from Brazilian endemic area. Lima-Junior JC, Rodrigues-da-Silva RN, Banic DM, Jiang J, Singh B, Fabrício-Silva GM, Porto LC, Meyer EV, Moreno A, Rodrigues MM, Barnwell JW, Galinski MR, de Oliveira-Ferreira J, PLoS One 2012 7 36419 10.1371/journal.pone.0036419 22649493
25. Partial protection against Plasmodium vivax blood-stage infection in Saimiri monkeys by immunization with a recombinant C-terminal fragment of merozoite surface protein 1 in block copolymer adjuvant. Yang C, Collins WE, Sullivan JS, Kaslow DC, Xiao L, Lal AA, Infect Immun 1999 67 342 349 9864235 (Pubitemid 29021668)
26. Immunization against malaria with a recombinant protein. Ling IT, Ogun SA, Holder AA, Parasite Immunol 1994 16 63 67 8015856 (Pubitemid 24176422)
27. Humoral response to a carboxyl-terminal region of the merozoite surface protein-1 plays a predominant role in controlling blood-stage infection in rodent malaria. Daly TM, Long CA, J Immunol 1995 155 236 243 7602100
28. Merozoite surface protein 1, immune evasion, and vaccines against asexual blood stage malaria. Holder AA, Guevara Patiño JA, Uthaipibull C, Syed SE, Ling IT, Scott-Finnigan T, Blackman MJ, Parassitologia 1999 41 409 414 10697894 (Pubitemid 129640287)
29. 19) of Plasmodium yoelii expressed in Saccharomyces cerevisiae: correlation of protection with antigen-specific antibody titer, but not with effector CD4+ T cells. Hirunpetcharat C, Tian JH, Kaslow DC, van Rooijen N, Kumar S, Berzofsky JA, Miller LH, Good MF, J Immunol 1997 159 3400 3411 9317139 (Pubitemid 127482099)
30. 19) induces protective immunity to blood stage malaria infection in mice. Hirunpetcharat C, Stanisic D, Liu XQ, Vadolas J, Strugnell RA, Lee R, Miller LH, Kaslow DC, Good MF, Parasite Immunol 1998 20 413 420 10.1046/j.1365-3024.1998. 00161.x 9767608 (Pubitemid 28432086)
31. Effects of cryopreservation on human lymphocyte functions: comparison of programmed freezing method by a direct control system with a mechanical freezing method. Ichino Y, Ishikawa T, J Immunol Methods 1985 77 283 290 10.1016/0022-1759(85)90041-9 3981006 (Pubitemid 15103675)
32. A rapid method for measuring apoptosis and dual-color immunofluorescence by single laser flow cytometry. Schmid I, Uittenbogaart CH, Keld B, Giorgi JV, J Immunol Methods 1994 170 145 157 10.1016/0022-1759(94)90390-5 8157993 (Pubitemid 24122504)
33. Human malaria parasites in continuous culture. Trager W, Jensen JB, Science 1976 193 673 675 10.1126/science.781840 781840
34. Cryopreservation of peripheral blood mononuclear cells does not affect the levels of spontaneous apoptosis after 24h culture. Riccio EKP, Neves-Júnior I, Riccio LRP, Banic DM, Daniel-Ribeiro CT, Ferreira-da-Cuz MF, Cryobiology 2002 45 127 134 10.1016/S0011-2240(02)00121-9 12482378 (Pubitemid 36132529)
35. Optimization and limitations of use of cryopreserved peripheral blood mononuclear cells for functional and phenotypic T-cell characterization. Weinberg A, Song LY, Wilkening C, Sevin A, Blais B, Louzao R, Stein D, Defechereux P, Durand D, Riedel E, Raftery N, Jesser R, Brown B, Keller MF, Dickover R, McFarland E, Fenton T, Clin Vaccine Immunol 2009 16 1176 1186 10.1128/CVI.00342-08 19515870
36. Role of Th1 and Th2 cytokines in immune response to uncomplicated Plasmodium falciparum malaria. Torre D, Speranza F, Giola M, Matteelli A, Tambini R, Biondi G, Clin Diagn Lab Immunol 2002 9 348 351 11874876 (Pubitemid 34226030)
37. Low CD4(+) T cell responses to the C-terminal region of the malaria merozoite surface protein-1 may be attributed to processing within distinct MHC class II pathways. Quin SJ, Seixas EM, Cross CA, Berg M, Lindo V, Stockinger B, Langhorne J, Eur J Immunol 2001 31 72 81 10.1002/1521-4141(200101)31:1<72:: AID-IMMU72>3.0.CO;2-Z 11169440
38. Blood stage malaria antigens induce different activation-induced cell death programs in splenic CD4 + T cells. Mukherjee P, Devi YS, Chauhan VS, Parasite Immunol 2008 30 497 514 10.1111/j.1365-3024.2008.01050.x 18643960
39. Activation-induced cell death in T cells. Green DR, Droin N, Pinkoski M, Immunol Rev 2003 193 70 81 10.1034/j.1600-065X.2003.00051.x 12752672 (Pubitemid 36688041)
40. Endogenous interleukin-10 modulates proinflammatory response in Plasmodium falciparum malaria. Ho M, Schollaardt T, Snape S, Looareesuwan S, Suntharasamai P, White NJ, J Infect Dis 1998 178 520 525 10.1086/515640 9697735 (Pubitemid 28347937)
41. The prognostic and pathophysiologic role of pro- and antiinflammatory cytokines in severe malaria. Day NP, Hien TT, Schollaardt T, Loc PP, Chuong LV, Chau TT, Mai NT, Phu NH, Sinh DX, White NJ, Ho M, J Infect Dis 1999 180 1288 1297 10.1086/315016 10479160 (Pubitemid 30070216)
42. Innate immune responses to human malaria: heterogeneous cytokine responses to blood-stage Plasmodium falciparum correlate with parasitological and clinical outcomes. Walther M, Woodruff J, Edele F, Jeffries D, Tongren JE, King E, Andrews L, Bejon P, Gilbert SC, De Souza JB, Sinden R, Hill AV, Riley EM, J Immunol 2006 177 5736 5745 17015763 (Pubitemid 44527649)
43. Pathology of Plasmodium chabaudi chabaudi infection and mortality in interleukin-10-deficient mice are ameliorated by anti-tumor necrosis factor alpha and exacerbated by anti-transforming growth factor beta antibodies. Li C, Sanni LA, Omer F, Riley E, Langhorne J, Infect Immun 2003 71 4850 4856 10.1128/IAI.71.9.4850-4856.2003 12933825 (Pubitemid 37070725)
44. IL-10: the master regulator of immunity to infection. Couper KN, Blount DG, Riley EM, J Immunol 2008 180 5771 5777 18424693
45. T cell-derived IL-10 and its impact on the regulation of host responses during malaria. Rosario AP F d, Langhorne J, Int J Parasitol 2012 42 549 555 10.1016/j.ijpara.2012.03.010 22549022
46. Functional conservation of the malaria vaccine antigen MSP-119across distantly related Plasmodium species. O'Donnell RA, Saul A, Cowman AF, Crabb BS, Nat Med 2000 6 91 95 10.1038/71595 10613831 (Pubitemid 30048533)
47. Mosaic organization and heterogeneity in frequency of allelic recombination of the Plasmodium vivax merozoite surface protein-1 locus. Putaporntip C, Jongwutiwes S, Sakihama N, Ferreira MU, Kho WG, Kaneko A, Kanbara H, Hattori T, Tanabe K, Proc Natl Acad Sci USA 2002 99 16348 16353 10.1073/pnas.252348999 12466500 (Pubitemid 35462798)
48. TLR-mediated cell signaling by malaria GPIs. Gowda DC, Trends Parasitol 2007 23 596 604 10.1016/j.pt.2007.09.003 17980663 (Pubitemid 350161430)
49. Antibody response to tetanus toxoide inoculation in malarious and non-malarious Gambian children. McGregor IA, Barr M, Trans R Soc Trop Med Hyg 1962 56 364 367 10.1016/0035-9203(62)90005-6
50. Antigen-specific immunosuppression in human malaria due to Plasmodium falciparum. Ho M, Webster HK, Looareesuwan S, Supanaranond W, Phillips RE, Chanthavanich P, Warrell DA, J Infect Dis 1986 3 763 771 (Pubitemid 16133760)
51. HLA class II and antibody responses to circumsporozoite protein repeats of P. vivax (VK210, VK247 and P. vivax-like) in individuals naturally exposed to malaria. Oliveira-Ferreira J, Pratt-Riccio LR, Arruda M, Santos F, Ribeiro CT, Goldberg AC, Banic DM, Acta Trop 2004 92 63 69 10.1016/j.actatropica.2004.02.011 15301976 (Pubitemid 39044600)
52. Antibody response profiles induced by Plasmodium falciparum glutamate-rich protein in naturally exposed individuals from a brazilian area endemic for malaria. Pratt-Riccio LR, Lima-Junior JC, Carvalho LJ, Theisen M, Espindola-Mendes EC, Santos F, Oliveira-Ferreira J, Goldberg AC, Daniel-Ribeiro CT, Banic DM, Am J Trop Med Hyg 2005 73 1096 1103 16354819 (Pubitemid 43038261)
53. Immunogenetic control of antibody responsiveness in a malaria endemic area. Carpenter D, Abushama H, Bereczky S, Färnert A, Rooth I, Troye-Blomberg M, Quinnell RJ, Shaw MA, Hum Immunol 2007 68 165 169 10.1016/j.humimm.2006.12.002 17349871 (Pubitemid 46371334)
54. Influence of HLA-DRB-1 alleles on the production of antibody against CSP, MSP-1, AMA-1, and DBP in Brazilian individuals naturally infected with Plasmodium vivax. Storti-Melo LM, da Costa DR, Souza-Neiras WC, Cassiano GC, Couto VS, Póvoa MM, Soares Ida S, de Carvalho LH, Arevalo-Herrera M, Herrera S, Rossit AR, Cordeiro JA, de Mattos LC, Machado RL, Acta Trop 2012 121 152 155 10.1016/j.actatropica.2011.10.009 22107686
55. Association of HLA-G 3′ untranslated region polymorphisms with antibody response against Plasmodium falciparum antigens: preliminary results. Sabbagh A, Courtin D, Milet J, Massaro JD, Castelli EC, Migot-Nabias F, Favier B, Rouas-Freiss N, Moreau P, Garcia A, Donadi EA, Tissue Antigens 2013 82 53 58 10.1111/tan.12140 23745572
56. IgE versus IgG4 production can be differentially regulated by IL-10. Jeannin P, Lecoanet S, Delneste Y, Gauchat JF, Bonnefoy JY, J Immunol 1998 160 3555 3561 9531318 (Pubitemid 28164751)
57. Similar cytokine responses and degrees of anemia in patients with Plasmodium falciparum and Plasmodium vivax infections in the Brazilian Amazon region. Fernandes AA, Carvalho LJ, Zanini GM, Ventura AM, Souza JM, Cotias PM, Silva-Filho IL, Daniel-Ribeiro CT, Clin Vaccine Immunol 2008 15 650 658 10.1128/CVI.00475-07 18256207 (Pubitemid 351967055)
58. Anti-Plasmodium vivax duffy binding protein antibodies measure exposure to malaria in the Brazilian Amazon. Cerávolo IP, Bruña-Romero O, Braga EM, Fontes CJ, Brito CF, Souza JM, Krettli AU, Adams JH, Carvalho LH, Am J Trop Med Hyg 2005 72 675 681 15964949 (Pubitemid 41278783)
59. Comparison of IgG reactivities to Plasmodium vivax merozoite invasion antigens in a Brazilian Amazon population. Tran TM, Oliveira-Ferreira J, Moreno A, Santos F, Yazdani SS, Chitnis CE, Altman JD, Meyer EV, Barnwell JW, Galinski MR, Am J Trop Med Hyg 2005 73 244 255 16103583 (Pubitemid 41278692)
60. Elevated anti-malarial IgE in asymptomatic individuals is associated with reduced risk for subsequent clinical malaria. Bereczky S, Montgomery SM, Troye-Blomberg M, Rooth I, Shaw MA, Färnert A, Int J Parasitol 2004 34 935 942 10.1016/j.ijpara.2004.04.007 15217732 (Pubitemid 38813255)
61. Immune responses elicited by co-immunization of Plasmodium vivax and P. falciparum MSP-1 using prime-boost immunization strategies. Mehrizi AA, Zakeri S, Rafati S, Salmanian AH, Djadid ND, Parasite Immunol 2011 33 594 608 10.1111/j.1365-3024.2011.01331.x 21883290